<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Shao L</submitter><funding>Central South University</funding><funding>Changsha Association for Science and Technology</funding><pagination>32</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12831273</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>26(1)</volume><pubmed_abstract>Approximately 5-10% of all cancer types are hereditary cancer syndromes, which are caused by pathogenic mutations in cancer susceptibility genes. In this investigation, a hereditary cancer pedigree was collected from a province in southern China, and the proband was a 31-year-old woman with breast cancer. Utilizing blood whole exome sequencing technology and bioinformatics analysis, the sole heterozygous missense mutation in PIBF1 that exhibits trait segregation was identified: PIBF1 (p.R405Q). The pedigree also included two other mutations that may be linked to carcinogenesis: RAD51D (p.K91Ifs*13) and BRCA2 (p.G3134Afs*29). This research concentrated on PIBF1 (p.R405Q) and employed breast cancer as a tumor model. In vitro and in vivo experiments showed that PIBF1-WT suppressed breast canc</pubmed_abstract><journal>Cancer cell international</journal><pubmed_title>PIBF1 (p.R405Q) germline variant identified in cancer susceptibility family impairs protein stability and function.</pubmed_title><pmcid>PMC12831273</pmcid><funding_grant_id>2024ZZTS0509</funding_grant_id><funding_grant_id>No. AY-2024-01-023</funding_grant_id><pubmed_authors>Liu X</pubmed_authors><pubmed_authors>Wu J</pubmed_authors><pubmed_authors>Yu R</pubmed_authors><pubmed_authors>Wen L</pubmed_authors><pubmed_authors>Shao L</pubmed_authors><pubmed_authors>Xu Q</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors><pubmed_authors>Zhang S</pubmed_authors><pubmed_authors>Zhao J</pubmed_authors></additional><is_claimable>false</is_claimable><name>PIBF1 (p.R405Q) germline variant identified in cancer susceptibility family impairs protein stability and function.</name><description>Approximately 5-10% of all cancer types are hereditary cancer syndromes, which are caused by pathogenic mutations in cancer susceptibility genes. In this investigation, a hereditary cancer pedigree was collected from a province in southern China, and the proband was a 31-year-old woman with breast cancer. Utilizing blood whole exome sequencing technology and bioinformatics analysis, the sole heterozygous missense mutation in PIBF1 that exhibits trait segregation was identified: PIBF1 (p.R405Q). The pedigree also included two other mutations that may be linked to carcinogenesis: RAD51D (p.K91Ifs*13) and BRCA2 (p.G3134Afs*29). This research concentrated on PIBF1 (p.R405Q) and employed breast cancer as a tumor model. In vitro and in vivo experiments showed that PIBF1-WT suppressed breast canc</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Dec</publication><modification>2026-06-21T03:11:34.694Z</modification><creation>2026-06-21T03:07:39.254Z</creation></dates><accession>S-EPMC12831273</accession><cross_references><pubmed>41419868</pubmed><doi>10.1186/s12935-025-04132-y</doi></cross_references></HashMap>